Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. (Q34661875)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. |
scientific article |
Statements
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia (English)
Patrick F Sullivan
Jeffrey A Lieberman
Daniel E Adkins
Jozsef Bukszár
Amit N Khachane
Richard S E Keefe
Diana O Perkins
Joseph P McEvoy
Robert E Vann
Patrick M Beardsley
Edwin J C G van den Oord
24 November 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference